PrognomIQ private stock trade

PrognomIQ

Legal NamePrognomIQ, Inc.
HeadquartersRedwood City
SectorBioTech

Developer of multi-omics tests intended to facilitate early and accurate diagnosis and detection of cancer and complex diseases. The company leverages Proteograph technology, genomics and other omics data for unbiased proteomic analysis, enabling the medical community to improve diagnostic tests and recurrence monitoring of critical diseases.

Learn more about PrognomIQ IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for PrognomIQ, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for PrognomIQ, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.